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This study provides further insight into the molecular mechanisms that control neurotransmitter release. Experiments were
performed on larval neuromuscular junctions of transgenic Drosophila melanogaster lines with diﬀerent levels of human
amyloid precursor protein (APP) production. To express human genes in motor neurons of Drosophila, the UAS-GAL4 system
was used. Human APP gene expression increased the number of synaptic boutons per neuromuscular junction. The total
number of active zones, detected by Bruchpilot protein puncta distribution, remained unchanged; however, the average number
of active zones per bouton decreased. These disturbances were accompanied by a decrease in frequency of miniature excitatory
junction potentials without alteration in random nature of spontaneous quantal release. Similar structural and functional
changes were observed with co-overexpression of human APP and β-secretase genes. In Drosophila line with expression of
human amyloid-β42 peptide itself, parameters analyzed did not diﬀer from controls, suggesting the speciﬁcity of APP eﬀects.
These results conﬁrm the involvement of APP in synaptogenesis and provide evidence to suggest that human APP
overexpression speciﬁcally disturbs the structural and functional organization of active zone and results in altered Bruchpilot
distribution and lowered probability of spontaneous neurotransmitter release.
1. Introduction
Increased synthesis and accumulation of amyloid-β-protein
(Aβ) that is produced through proteolytic processing of amy-
loid precursor protein (APP) by β- and γ-secretases is con-
sidered to be a major cause of Alzheimer’s disease [1–3].
Data obtained on mammals indicate that APP takes part in
synapse formation and in the regulation of synaptic and neu-
ronal function, and alteration of APP expression aﬀects cog-
nitive and memory processes [4–6]. However, present
mammalian experimental models do not allow the eﬀects of
APP and Aβ to be studied separately. One of the convenient
models in this regard is Drosophila melanogaster. Drosophila
endogenously express orthologue to the human APP (APPL),
but it lacks the Аβ peptide region [7]. In Drosophila, all com-
ponents of the protein complex responsible for the activity of
γ-secretase are present and functional homolog of the β-
secretase (BACE) has also been identiﬁed, but its activity is
extremely low [8]. Therefore, in transgenic lines of Drosoph-
ila, it is possible to separate and study the eﬀects of APP and
Aβ independently. It has been demonstrated that APPL reg-
ulates synaptic structure and promotes synapse diﬀerentia-
tion at the neuromuscular junction (NMJ) [9]. Experiments
with expression of the human APP gene in Drosophila mela-
nogaster demonstrated neurodegenerative changes, altered
cognition and memory processes, changes in locomotion
behavior, and multiple morphofunctional changes in the
NMJ [10–14]. In addition, altered presynaptic function and
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decreased levels of the synaptic vesicle exocytosis proteins
synaptotagmin and synaptobrevin were observed [12, 15].
Proteins that regulate vesicle exocytosis cluster at presyn-
aptic active zones (AZs) that organize the synaptic release
machinery to maintain and regulate synaptic transmission
eﬃciency [16, 17]. AZs provide precise spatial and temporal
control of vesicle fusion, and AZs spacing is a subject of
special attention [18–21]. Notably, APP localizes to AZs
and interacts with exocytosis cascade proteins, implicating
APP as a potential player in neuronal communication and
signaling [22–24].
Bruchpilot (Brp) is known to be the key scaﬀold protein
of the AZ in Drosophila, and AZs were identiﬁed as Brp-
positive puncta [19–21, 25]. This study examines the possi-
bility that APP can be involved in the control of structural
and functional presynaptic AZ organization. To test this,
we analyzed the eﬀects of human APP gene expression on
Brp and AZs distribution as well as spontaneous quantal
neurotransmitter release in the larval NMJ of transgenic
Drosophila melanogaster lines.
2. Materials and Methods
2.1. Drosophila Strains. We used the following transgenic
lines of Drosophila melanogaster: UAS-APP carries the
human APP gene (hereinafter, APP), UAS-BACE carries the
human BACE gene, double transgenic lines coexpressing
human APP and BACE genes (hereinafter, APP+BACE),
and UAS-Aβ42 carries the sequence of the human Aβ42 pep-
tide (hereinafter, Aβ). Line GAL4-D42 was used to drive
transgene expression in the motor neurons and as control
(hereinafter, control). w1118 was used to generate outcrossed
control. All transgenes and control were examined in the
heterozygous state. The UAS-BACE was kindly provided by
R. Reifegerste, and all other stocks were obtained from the
Drosophila Bloomington Stock Center. During the study,
the ﬂies were kept on the standard yeast medium at a temper-
ature of 25°C and a photoperiod of 12h.
2.2. Sample Preparation and Immunohistochemistry. Third
instarDrosophilamelanogaster larvaewere dissected in freshly
preparedphosphatebuﬀer (PBS) and thenﬁxedwith4%form-
aldehyde (Sigma-Aldrich, United States) for 20min, washed
with PBS, blocked in blocking buﬀer (Visual Protein Blocking
Buﬀer) for 1 hr, incubatedwithprimary antibodync82 speciﬁc
to Bruchpilot (1 : 200, DSHB) overnight at 4°C and then with
secondary antibodies Су-3 (1 : 200, Jackson ImmunoRe-
search) and with antibodies speciﬁc to HRP, conjugated with
Alexa Fluor 488 (1 : 400, Jackson ImmunoResearch) for 2 hr
at room temperature. Samples were mounted in VectaShield
(Vector Laboratories) and visualized under a Leica DMI6000
confocal microscope equipped with a 40x, 1.3 NA objective
(Leica, Germany) at 488nm and 543nm. Confocal images of
muscle 4 NMJ containing 1b boutons were analyzed. Satellite
boutons were deﬁned as small protrusions emanating from
the primary axial branch of nerve terminals. A number of con-
focal images of muscle 6 and 7NMJs were also analyzed. NMJ
morphology was estimated with Leica Application Suite X
software (Leica, Germany). Brp clusters (and corresponding
AZs) were counted manually.
The primary antibody nc82 was obtained from the
Developmental Studies Hybridoma Bank, created by the
NICHD of the NIH and maintained at the University of
Iowa, Department of Biology, Iowa City, IA 52242.
2.3. Electrophysiology. Electrophysiological experiments were
performed on freshly prepared third instar Drosophila larvae
in HL3 saline (in mM: 70 NaCl, 5 KCl, 20 MgCl2, 2 CaCl2, 10
NaHCO3, 5 Trehalose, 115 sucrose, 5 HEPES, pH7.2). Larvae
were dissected and prepared in low Ca2+ (0.2mM) HL3
saline at 4°С. After preparation, larvae were maintained
in a Plexiglas chamber continuously perfused with normal
HL3 saline (containing 2mM Ca2+) using a BT-100 two-
channel peristaltic pump (Leadﬂuid Co). The solution was
continuously aerated with a 95% O2 and 5% CO2 gas mixture
and maintained at 22°C using a CL-100 bipolar temperature
controller equipped with a SC-20 heating/cooling element
(Warner Instruments, USA). Spontaneous neurotransmitter
release was monitored by intracellularly recording miniature
excitatory junction potentials (mEJPs). Resting membrane
potentials and mEJPs were recorded from muscle ﬁbers 6
and 7 using glass microelectrodes with internal capillaries
BF150-110-10, made with a P-97 microforge (Sutter Instru-
ment Co., USA). The electrodes were ﬁlled with 3M KCl
and their resistance was about 10mOhm. Recordings were
made in junctional membrane regions within visually identi-
ﬁed terminal branches of the motor nerve using the binocular
PZMTIII microscope (WPI). The resting membrane
potentials and mEJPs were ampliﬁed and digitized using
the Axoclamp 900A and the Digidata 1440A (Molecular
devices, USA), with automated data statistics processing
(PC Clamp 10.0). Spontaneous mEJPs were recorded for
3–6min, and the average parameters of the spontaneous
events were quantiﬁed. Only recordings with stable resting
membrane potential below −60mV throughout the course
of the experiment were analyzed. Peak amplitude, rise time
(10% to 90% of the baseline-to-peak amplitude range), and
time to decay half-amplitude of individual mEJPs were
digitized and analyzed.
2.4. Statistical Analysis. Data are given as the mean± SEM.
Statistical signiﬁcance of the diﬀerence between means
was evaluated using Student’s t-test and one-way ANOVA
(OriginPro 8 software). Cumulative probability distribu-
tions were compared with the Kolmogorov-Smirnov test
(GraphPad Prism 7 software).
3. Results
3.1. Human APP Gene Expression Speciﬁcally Alters Active
Zone Distribution. Muscle 4 NMJs in APP and APP+BACE
lines demonstrated a signiﬁcant (P < 0 01) increase in the
number of both 1b and satellite boutons per NMJ com-
pared to the control; accordingly, total bouton number
per NMJ also increased (Table 1). These data provide fur-
ther evidence that human APP overexpression enhances
proliferation and synaptogenesis and conﬁrms similar
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observations previously obtained in Drosophila melanoga-
ster [9, 12]. In conditions of direct expression of Aβ (line
Aβ), the average number of boutons of both types did not
diﬀer from the control (Table 1).
The localization of individual AZs was determined by
Brp protein clusters (Figure 1). In APP and APP+BACE
lines, the average number of AZs per 1b bouton was signiﬁ-
cantly (P < 0 01) lower than that in the control, and a similar
eﬀect was observed in satellite boutons (Table 1). Neverthe-
less, the total AZ number per NMJ did not diﬀer from that
in the control (Table 1), presumably due to increased synap-
tic bouton number that compensates AZs loss. In the Aβ line,
the number of AZs per bouton did not signiﬁcantly diﬀer
from that in the control (Table 1).
Distribution of Brp clusters (AZs) in individual 1b bou-
tons (Figure 2(a)) and corresponding cumulative probability
curves (Figure 3(a)) in APP and APP+BACE lines were
signiﬁcantly (P < 0 01, Kolmogorov-Smirnov test) shifted
towards fewer numbers compared to the control. A similar
eﬀect was observed for satellite boutons (Figures 2(b) and
3(b)). In the Aβ line, AZs distributions and cumulative prob-
ability curves did not diﬀer from the control (Figures 2 and 3).
A very small fraction of satellite boutons (3% in the con-
trol) did not contain AZs at all and presumably could be
referred to ghost boutons [26]. In APP and APP+BACE lines,
the number of satellite boutons containing no AZs was
higher than in the control, while this eﬀect was not observed
in the Aβ line (Figure 2(b)). These data further conﬁrm that
human APP overexpression alters the AZ distribution.
Importantly, the enhanced synaptogenesis accompanied
by the alteration of AZ distribution observed in APP and
APP+BACE lines was not observed in the Aβ line. This
suggests that the observed eﬀects are speciﬁc to APP and
not related to Aβ production.
Notably, neuron-type speciﬁcity at muscle 4 NMJ com-
pared to muscle 6 and 7 NMJs regarding Drosophila neuro-
trophins was observed [26]. To test whether the eﬀects of
APP is neuron-type speciﬁc or not, a number of confocal
Table 1: Parameters of muscle 4 neuromuscular junctions of transgenic Drosophila melanogaster larvae.
Parameters Control APP APP+BACE Aβ
1b bouton number per NMJ 25± 2 49± 4∗∗ 47± 3∗∗ 26± 1
Satellite bouton number per NMJ 7.1± 0.8 21.6± 2.0∗∗ 12.5± 0.7∗∗ 7.3± 0.7
Total bouton number per NMJ 32± 2 71± 6∗∗ 60± 3∗∗ 33± 2
Brp clusters (active zones) number per 1b bouton 7.2± 0.2 4.3± 0.1∗∗ 4.3± 0.1∗∗ 7.5± 0.1
Brp clusters (active zones) number per satellite bouton 2.5± 0.1 1.7± 0.1∗∗ 1.6± 0.1∗∗ 2.4± 0.1
Total Brp clusters (active zones) number per NMJ 174± 8 178± 12 188± 10 194± 8
Number of NMJ 36 31 45 59
Number of larvae 9 10 17 26
Data are presented as mean ± SEM. ∗∗P < 0 01 compared to the control.
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Figure 1: Muscle 4 neuromuscular junction. Bruchpilot and corresponding active zone distribution in synaptic boutons from transgenic
Drosophila melanogaster larvae. (a) 1b boutons. (b) Satellite boutons (identiﬁed by arrowheads). Representative confocal images from the
control, APP, APP+BACE, and Аβ lines are shown. Muscle 4 neuromuscular junctions were costained with antibodies against HRP (green
channel) and the presynaptic AZ protein Brp (red channel). Scale bars, 5μm (a) and 2μm (b).
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images of muscle 6 and 7 NMJs containing both 1b and 1s
boutons were analyzed additionally (Figure 4(a)). The aver-
age number of AZs per bouton in the APP line (4.3± 0.1; 6
NMJ from 6 larvae) and in APP+BACE line (4.5± 0.1; 9
NMJ from 6 larvae) were signiﬁcantly (P < 0 01) lower than
that in the control (5.8± 0.2; 11 NMJ from 6 larvae).
Conversely, in the Aβ line, the number of AZs per bouton
(6.4± 0.2; 9 NMJ from 5 larvae) tend to increase compared
to that in the control (Figure 4(b)).
Additionally, to test if APP aﬀects AZ spatial density, area
of each individual bouton (Figure 4(c)) and the number of
AZs per corresponding bouton area were estimated. The
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Figure 2: Muscle 4 neuromuscular junction. Bruchpilot cluster (active zone) distribution in individual synaptic boutons from transgenic
Drosophila melanogaster larvae. Distributions for the control, APP, APP+BACE, and Аβ lines are shown. (a) 1b boutons. (b) Satellite
boutons; arrowheads identify the boutons containing no AZs. Insets—circle charts showing percentage of satellite boutons containing no
AZs. N—active zone number per single bouton.
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Figure 4: Muscle 6 and 7 neuromuscular junctions. (a) Bruchpilot and corresponding active zones distribution in synaptic boutons from
transgenic Drosophila melanogaster larvae. Representative confocal images from the control, APP, APP+BACE, and Аβ lines are shown.
Muscle 6 and 7 neuromuscular junctions were costained with antibodies against HRP (green channel) and the presynaptic AZ protein Brp
(red channel). Scale bars, 25 μm. (b) Average number of active zones per bouton. (c) Average boutons area, μm2. (d) Spatial density of
AZs per μm2. Data are presented as mean± SEM. ∗∗P < 0 01 compared to corresponding bar.
0 5 10 15 20 25 30
0
20
40
60
80
100
N
Cu
m
ul
at
iv
e c
ou
nt
s (
%
)
Control
АРР
АРР+ВАСЕ
А𝛽
(a)
0 2 4 6 8 10
0
20
40
60
80
100
N
Cu
m
ul
at
iv
e c
ou
nt
s (
%
)
Control
АРР
АРР+ВАСЕ
А𝛽
(b)
Figure 3: Muscle 4 neuromuscular junction. Cumulative probability of Bruchpilot cluster (active zone) distribution in individual synaptic
boutons from transgenic Drosophila melanogaster larvae. (a) 1b boutons. (b) Satellite boutons. Control line—open circles; APP
line—squares; APP+BACE line—triangles; and Аβ line—ﬁlled circles. The distribution of AZs per bouton in the APP and APP+BACE
lines are signiﬁcantly shifted toward fewer numbers compared to the control (P < 0 01, Kolmogorov-Smirnov test). In the Аβ line,
cumulative probability is not signiﬁcantly diﬀerent from the control. N—active zone number per single bouton.
5Neural Plasticity
Control
APP
APP+BACE
A𝛽
(a)
M
EJ
P 
fre
qu
en
cy
 (H
z)
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
C
on
tro
l
A
PP
A
PP
+
BA
CE A
𝛽
⁎⁎
⁎⁎
⁎⁎
(b)
Control
n
70
60
50
40
30
20
10
0
0 1000 2000
Inverval (ms)
3000 4000
𝜏 = 417 ± 16 ms
(c)
n
50
40
30
20
10
0
0 1000 2000
Inverval (ms)
3000 4000
APP
𝜏 = 899 ± 38 ms
(d)
n
70
60
50
40
30
20
10
0
0 1000 2000
Inverval (ms)
3000 4000
APP+BACE
𝜏 = 650 ± 28 ms
(e)
n
70
60
50
40
30
20
10
0
0 1000 2000
Inverval (ms)
3000 4000
A𝛽
𝜏 = 510 ± 21 ms
(f)
Figure 5: mEJPs recoded at muscle ﬁber 6 and 7 neuromuscular junctions from transgenic Drosophila melanogaster larvae. (a) Sample of
original mEJP traces from representative individual experiments. Calibration: vertical, 1mV; horizontal, 200ms. (b) Average mEJPs
frequency. (c–f) Distribution of inter-event intervals between mEJPs recorded in representative individual experiments. (c) Control, (d)
APP, (e) APP+BACE, and (f) Аβ lines. Curve ﬁtting assuming a monoexponential decay conﬁrming the random nature of spontaneous
neurotransmitter release in all Drosophila lines. τ—the time constants, obtained from corresponding monoexponential ﬁtting. Data are
presented as mean± SEM. ∗∗P < 0 01 compare to corresponding bar.
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average spatial density of AZs per μm2 in the control line was
1.27± 0.02 (382 boutons), and this parameter was signiﬁ-
cantly (P < 0 01) lower both in APP (1.01± 0.02 per μm2;
322 boutons) and in APP+BACE (1.03± 0.02 per μm2; 534
boutons) lines (Figure 4(d)). Again, in the Aβ line, the spatial
density of AZs (1.18± 0.02 per μm2; 381 boutons) was signif-
icantly (P < 0 01) higher compared to APP and APP+BACE
lines and was similar to the control (Figure 4(d)). These data
indicate that spatial density of AZs changes in the same way
as the number of AZs per bouton (Figures 4(b) and 4(d)).
3.2. Human APP Gene Expression Speciﬁcally Alters
Spontaneous Neurotransmitter Release.mEJPs were recorded
from muscle ﬁbers 6 and 7 as more convenient for electro-
physiology (Figure 5(a)). Previously, it was shown that
human APP gene expression (in APP and APP+BACE lines)
decreases the mEJPs frequency suggesting alterations in syn-
aptic vesicle exocytosis mechanism [27]. To further reveal the
background mechanism, in this study, we performed mEJP
recordings simultaneously with corresponding confocal
imaging and both pre- and postsynaptic mEJPs characteris-
tics were analyzed in detail. Finally, the major novelty of
mEJPs recording in this study is the use of Aβ line that pro-
vides the possibility to actually separate APP and Aβ eﬀects.
Human APP gene expression signiﬁcantly (P < 0 01)
decreased mean mEJPs frequency by 41% compared to the
control. In the APP+BACE line, mEJPs frequency also was
signiﬁcantly (P < 0 01) decreased by 34%. Conversely, in
the Aβ line, mEJP frequency was signiﬁcantly (P < 0 01)
increased compared to the APP and APP+BACE lines; no
diﬀerence compared to the control line was observed
(Figure 5(b), Table 2).
Spontaneous neurotransmitter release is a random pro-
cess and as such can be described by a Poisson model. Distri-
bution of mEJPs latencies in all lines were best-ﬁtted with a
monoexponential equation predicted by the Poisson model
well, thus conﬁrming that under all experimental conditions,
the random nature of spontaneous quantal release is not
altered. However, as expected from the higher mEJP fre-
quency in the control and Aβ lines, the time constants (τ)
of distribution were increased in the APP and APP+BACE
lines (Figures 5(c), 5(d), 5(e), and 5(f)).
It was observed that the mean peak amplitude and the
rise time and decay time of mEJPs, obtained in the control
line, were not signiﬁcantly changed in APP, APP+BACE,
and Aβ lines (Table 2). Notably, the mEJP amplitude distri-
bution in the control line was best ﬁtted by a Gaussian two-
peak model with mean peaks at 0.68mV and 1.15mV
(Figure 6(a)). The ratio of these peaks (1.15/0.68 =1.69) cor-
responds well with the observation that quantal size is 53%
larger for 1s boutons than for 1b boutons [28]. Accordingly,
our data provide the evidence to suggest that “small” and
“big”mEJPs in the bimodal distribution were generated from
1b and 1s presynaptic boutons, respectively. Similar bimodal
distributions with analogous peaks were obtained in all
Drosophila lines (Figures 6(a), 6(b), 6(c), and 6(d)) and no
pronounced diﬀerences from the control line were observed
(Figure 6(e)). Cumulative probability curves for amplitude
distribution of total mEJPs number also did not diﬀer from
the control (Figure 6(f)).
In summary, these results provide evidence that human
APP overexpression speciﬁcally lowers spontaneous neuro-
transmitter release without essential APP-induced alterations
in quantal size and/or postsynaptic events.
4. Discussion
AZs represent specialized regions of the presynaptic mem-
brane where quantal neurotransmitter release occurs via syn-
aptic vesicle exocytosis [16, 17]. These highly speciﬁc
compartments contain synaptic vesicles and serve as a
molecular platform for specialized proteins involved in
the organization and regulation of neurotransmitter release
[18–21]. Accumulated data indicate that APP not only
localizes in AZs but also functionally and molecularly
interacts with several key proteins of the vesicular exocyto-
sis molecular machinery. Among the APP-associated pro-
teins, a number of components necessary for synaptic
vesicle fusion have been identiﬁed [22–24]. In particular,
altered distribution of a core SNARE complex protein,
synaptobrevin, accompanied by disturbances in synaptic
vesicle turnover under APP overexpression was observed
[12]. It has also been shown that APP altered expression
of the calcium sensor synaptotagmin-1 [15]. Moreover, it
has been demonstrated that APP localizes to synaptic
vesicles in close association with synaptotagmin-1 and
might thus play a role in the regulation of synaptic vesicle
exocytosis [22].
It has been shown that AZ spacing is regulated by diﬀer-
ent mechanisms [18, 29]. Our data provide the ﬁrst evidence
that human APP gene expression alters AZ distribution, spe-
ciﬁcally decreasing Brp cluster number per single synaptic
bouton including satellite boutons. Notably, APP overexpres-
sion did not alter total AZ number per NMJ. Consequently,
Table 2: Parameters of mEJPs recoded at muscle 6 and 7 neuromuscular junctions from transgenic Drosophila melanogaster larvae.
mEJPs parameter Control APP APP+BACE Aβ
Peak amplitude (mV) 1.0± 0.1 1.0± 0.1 1.1± 0.1 1.1± 0.1
Rise time (ms) 7.5± 0.3 9.2± 0.4 9.4± 0.4 9.2± 0.3
Decay time (ms) 29.6± 0.8 33.8± 0.8 33.4± 1.3 34.0± 0.9
Frequency (Hz) 2.7± 0.2 1.6± 0.2∗∗ 1.8± 0.3∗∗ 2.7± 0.4
Number of NMJ 44 30 15 34
Number of larvae 16 12 6 14
Data are presented as mean ± SEM. ∗∗P < 0 01 compared to the control.
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Figure 6: Distribution of mEJPs amplitudes recorded at muscle ﬁber 6 and 7 neuromuscular junctions from transgenic Drosophila
melanogaster larvae. (a) Control, (b) APP, (c) APP+BACE, and (d) Аβ lines. Amplitude histograms show similar two-peak nature of
mEJPs distributions in all lines (double Gaussian ﬁts are shown). (e) The average amplitude of two peaks from mEJPs amplitude
distribution (a–d). (f) Cumulative histogram of the mEJPs amplitude distribution. Total mEJPs number for corresponding distributions
(a–d) are included. Data are presented as mean± SEM.
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APP-induced decrease of spontaneous neurotransmitter
release frequency can be explained by lowered vesicular exo-
cytosis probability rather than by AZ number change.
The role of Brp per se in these phenomena is not clear and
remains to be elucidated. Brp is known to be the major struc-
tural and functional scaﬀold protein of the AZ in Drosophila
[19–21, 25]. This protein is oriented perpendicularly to the
AZmembrane and its membrane-proximal N terminus helps
to spatial arrangement andclusteringof calciumchannels.The
C-terminus of Brp reaches into the cytoplasm of synaptic bou-
tons to tether and dock synaptic vesicles. In addition, at the
Drosophila melanogaster NMJ, Brp functionally and molecu-
larly interacts with the calcium sensor synaptotagmin [30].
Taken together, all these features provide evidence to suggest
a correlation between Brp spacing and neurotransmitter
release probability [19, 31]. Accordingly, at Brp mutant,
evoked vesicle release was depressed; however, the mEJPs fre-
quency was not signiﬁcantly altered [25]. To explain this dif-
ference, it should be noted that at Drosophila, spontaneous
and evoked release are independently regulated at individual
AZs [32]. In our experiments, APP-induced Brp loss was
accompanied by a signiﬁcant decrease in spontaneous neuro-
transmitter release, suggesting the involvement of additional
APP-dependent factors. In sum, to gain further insight into
the possible interplay between Brp distribution and spontane-
ous quantal release, special investigations are required.
5. Conclusions
Our data demonstrate that human APP overexpression
enhances synaptogenesis accompanied by altered AZs distri-
bution and lowered spontaneous neurotransmitter release.
Presumably, APP overexpression speciﬁcally disturbs the
vesicular exocytosis probability without alteration in the ran-
dom nature of spontaneous quantal release. These eﬀects are
APP speciﬁc and do not depend on Аβ production. Taken
together, our observation suggests that human APP gene
expression disturbs both structural and functional organiza-
tion of AZs resulting in altered spontaneous neurotransmit-
ter release and that these eﬀects are speciﬁc for APP.
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